Low dose naloxone enhances buprenorphine in a tooth pulp antinociceptive assay
- PMID: 3365064
Low dose naloxone enhances buprenorphine in a tooth pulp antinociceptive assay
Abstract
Low dose naloxone was reported to produce analgesia of long duration in patients who received buprenorphine. A rabbit tooth pulp antinociceptive model was utilized to evaluate a possible interaction of buprenorphine and naloxone. Naloxone (0.001 mg/kg i.v.) 210 min after buprenorphine (0.10 mg/kg i.v.) significantly increased the % MPE from 48 +/- 5% to 78 +/- 6%. This increased activity occurred within 90 min after naloxone injection and had a duration of 2 hr. Naloxone, 0.1 mg/kg, or saline 0.1 ml/kg did not increase nor reduce the buprenorphine antinociceptive effect. Naloxone alone (0.001 mg/kg) produced a peak antinociceptive effect of 43 +/- 14% MPE which was significantly greater than that of the saline control group. Using a graded dose response paradigm in the rabbit tooth pulp model, the graded dose response curve of buprenorphine was significantly shifted upwards after preadministration of 0.001 mg/kg naloxone. The slopes of both the ascending and descending limbs of the biphasic buprenorphine dose response curves were not significantly different. The peak % MPE achieved by buprenorphine in the presence of 0.001 mg/kg naloxone (62 +/- 8%) was significantly greater than the buprenorphine-saline control (23 +/- 4%). It appears that a low dose of naloxone produces antinociception which enhances that of buprenorphine.
Similar articles
-
Antinociceptive profiles of mu and kappa opioid agonists in a rat tooth pulp stimulation procedure.J Pharmacol Exp Ther. 1986 Jan;236(1):111-7. J Pharmacol Exp Ther. 1986. PMID: 2867210
-
Enhanced buprenorphine analgesia with the addition of ultra-low-dose naloxone in healthy subjects.Clin Pharmacol Ther. 2008 Jan;83(1):144-52. doi: 10.1038/sj.clpt.6100262. Epub 2007 Jun 13. Clin Pharmacol Ther. 2008. PMID: 17568402 Clinical Trial.
-
Buprenorphine in combination with naloxone at a ratio of 15:1 does not enhance antinociception from buprenorphine in healthy cats.Vet J. 2012 Jun;192(3):523-4. doi: 10.1016/j.tvjl.2011.09.008. Epub 2011 Oct 24. Vet J. 2012. PMID: 22030474 Clinical Trial.
-
Imipramine-fentanyl antinociception in a rabbit tooth pulp model.Life Sci. 1991;49(18):1279-88. doi: 10.1016/0024-3205(91)90191-d. Life Sci. 1991. PMID: 1921645
-
Effects of naloxone, diprenorphine, buprenorphine and etorphine on unpunished and punished food-reinforced responding in the squirrel monkey.J Pharmacol Exp Ther. 1984 Mar;228(3):669-75. J Pharmacol Exp Ther. 1984. PMID: 6707916
Cited by
-
Potentiation of pentazocine analgesia by low-dose naloxone.J Clin Invest. 1988 Nov;82(5):1574-7. doi: 10.1172/JCI113768. J Clin Invest. 1988. PMID: 3183054 Free PMC article. Clinical Trial.
-
Agonist-antagonist combinations in opioid dependence: a translational approach.Dipend Patologiche. 2010;5(1):17-24. Dipend Patologiche. 2010. PMID: 22448305 Free PMC article.
-
Ultra low-dose naloxone and tramadol/acetaminophen in elderly patients undergoing joint replacement surgery: a pilot study.Pain Res Manag. 2009 Mar-Apr;14(2):103-8. doi: 10.1155/2009/497217. Pain Res Manag. 2009. PMID: 19532850 Free PMC article. Clinical Trial.
-
Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment.Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10540-4. doi: 10.1073/pnas.92.23.10540. Proc Natl Acad Sci U S A. 1995. PMID: 7479836 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources